Health & Medicine
FDA Approves Low-Dose Antidepressant, Brisdelle for Hot Flashes
The U.S. Food and Drug Administration has now approved Brisdelle, a non-hormonal drug, for treating hot-flashes in women.
Latest Research Articles
Breast Cancer Risk Lowered Through Consumption of Oily Fish: A Study
UK Announces Plans to Allow Controversial Three-person IVF
Runners Show Less Muscle Fatigue After 200 Miles than 100 Miles, Study Says
Sarah Murnaghan Awakes From Post-Surgery Coma, Put Back on Breathing Tube
Aspirin May Reduce Risk for Colon Cancer in Case of Key Gene Mutations : A Study
Brain Addicted to Food with High Glycemic Index
Brain Injury Associated with Higher Risk of Stroke
Vietnam War Veterans with PTSD at High Risk of Heart Disease
Potential Vaccine for Type-1 Diabetes Shows Promising Results in Clinical Trial
America's Cleanest and Dirtiest Beaches: A Report
Cutlery Type, Shape Alters Taste Perception
Use of Designer Drugs on the Rise: UN Report
MOST POPULAR
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Chinese Astronauts Create Oxygen and Rocket Fuel Using Artificial Photosynthesis in Space
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Contagious Urination Confirmed in Chimpanzees for the First Time, Surprising Researchers
